Drug Research
Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option...
Boston Pharmaceuticals announced a pioneering three-year out-license and option agreement with GlaxoSmithKline PLC. Boston Pharmaceuticals will become a preferred GSK partner for select pre-phase 2...
Drug Research
US FDA approves Janssen’s PONVORY for relapsing multiple sclerosis
The US FDA has approved the Janssen Pharmaceutical Companies of Johnson & Johnson’s (JNJ) PONVORY (ponesimod) for treating adults with relapsing forms of multiple sclerosis...
Drug Research
Gilead and Novo Nordisk Expand NASH Clinical Collaboration
Gilead Sciences, Inc. and Novo Nordisk A/S announced that the companies have expanded their clinical collaboration in non-alcoholic steatohepatitis (NASH).
The companies will conduct a Phase...
Drug Research
Tevogen Bio, BioCentriq Partner for COVID T-cell Therapy
Tevogen Bio has entered a partnership with BioCentriq, a New Jersey based cell and gene therapy development and manufacturing center, to support clinical manufacturing of...
Drug Research
Insilicos Chemistry42 AI system integrated into UCBs drug discovery...
Insilico Medicine, an AI drug discovery company, announced that UCB will integrate Insilico's Chemistry42â„¢ into UCB's internal drug discovery pipeline. UCB's early adoption of Insilico...
Drug Research
PsiVac and Lonza Enter a Strategic Agreement for the...
PsiVac, a subsidiary of Ixogen; a UK biotechnology research and development company focused on the development of new therapeutic cancer treatments for solid tumors, and...
Drug Research
Moderna Announces Supply Agreement to Provide 13 Million Doses...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a supply agreement with the Government of The Philippines for 13 million...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.